Automatic quantitation of localized <i>in vivo</i><sup>1</sup>H spectra with LCModel

NMR in Biomedicine - Tập 14 Số 4 - Trang 260-264 - 2001
Stephen W. Provencher1
1Max-Planck-Institute for Biophysical Chemistry, D-37070, Göttingen, Germany

Tóm tắt

AbstractThe LCModel method analyzes an in vivo spectrum as a Linear Combination of Model in vitro spectra from individual metabolite solutions. Complete model spectra, rather than individual resonances, are used in order to incorporate maximum prior information into the analysis. A nearly model‐free constrained regularization method automatically accounts for the baseline and lineshape in vivo without imposing a restrictive parameterized form on them. LCModel is automatic (non‐interactive) with no subjective input. Approximately maximum‐likelihood estimates of the metabolite concentrations and their uncertainties (Cramér‐Rao lower bounds) are obtained. LCModel analyses of spectra from users with fields from 1.5 to 9.4 T and a wide range of sequences, particularly with short TE, are used here to illustrate the capabilities and limitations of LCModel and proton MRS. Copyright © 2001 John Wiley & Sons, Ltd. Abbreviations used: Ala alanine Asp aspartate Cr creatine GABA γ‐aminobutyric acid Glc glucose Gln glutamine Glu glutamate GPC glycerophosphocholine GSH glutathione Ins myo‐inositol Lac lactate NAA N‐acetylaspartate NAAG N‐acetylaspartylglutamate PC phosphocholine PCr phosphocreatine PE phosphoethanolamine Scyllo scyllo‐inositol S/N signal‐to‐noise ratio Tau taurine.

Từ khóa


Tài liệu tham khảo

10.1002/mrm.1910300604

10.1016/0010-4655(82)90173-4

10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L

ProvencherSW HänickeW MichaelisT.Automated quantitation of localized1H MR spectrain vivo: capabilities and limitations.3rd Scientific Meeting of the Society of Magnetic Resonance Abstracts 1995;1952.

10.1002/nbm.1940080606

10.1002/mrm.1910350202

10.1006/jmre.1999.1895

10.1016/S0730-725X(99)00058-2

Provencher SW, 1995, New Prospects in Psychiatry. The Bio‐clinical Interface, 405

HofmannL SlotboomJ BoeschC KreisR.Model fitting of1H‐MR spectra of the human brain: incorporation of short‐T1components and evaluation of parameterized vs. non‐parameterized models.7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine Abstracts 1999;586.

ProvencherSW.Automated quantitation of localized1H MR spectrain vivoat short echo times with baseline distortion.5th Scientific Meeting of the International Society of Magnetic Resonance in MedicineAbstracts 1997;1411.

SailasutaN HurdRE ProvencherS.Automated prior knowledge fitting of over‐sampled J‐resolved spectra.6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine Abstracts 1998;1842.

Cady EB, 1997, Analysis of proton brain spectra from human infants by fitting linear combinations of model spectra, J. Magn. Reson. Anal., 3, 5

Frahm J, 1997, Advances in Neurochemistry, 329

10.1002/1531-8249(199903)45:3<369::AID-ANA13>3.0.CO;2-Q

McLeanMA ParkerGJM BarkerGJ.Automated production of quantitative metabolite maps from short echo time1H‐CSI of the brain.6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine Abstracts 1998;626.

WangY YangB NgTC.Differences of metabolites in mesial and lateral temporal lobes.7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine Abstracts 1999;1429.

10.1002/mrm.1910390110

10.1203/00006450-199910000-00019

10.1002/(SICI)1522-2594(199901)41:1<204::AID-MRM29>3.0.CO;2-7

ThielT PanowC HennigJ MartinE.Metabolic asymmetries as an early indicator for temporal lobe epilepsy in children. A comparison with EEG and high resolution MRI.7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine Abstracts 1999;1473.

10.1111/j.1528-1157.2000.tb00158.x

10.1016/S0022-510X(99)00105-7

10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.0.CO;2-9

10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO;2-I

Speck O, 1996, Grading and therapy monitoring of astrocytomas with 1H‐spectroscopy: preliminary study, Anticancer Res., 16, 1581

10.1007/BF00261659

10.1016/S0360-3016(99)00236-9

10.1016/S0730-725X(98)00168-4

10.1016/S0140-6736(96)04116-5

10.1016/S0925-4927(97)00016-4

10.1212/WNL.53.1.71

10.1016/S0730-725X(99)00002-8

10.1055/s-2007-973500

10.1007/s004150050434

10.1002/1531-8249(199912)46:6<925::AID-ANA18>3.0.CO;2-J

10.1016/S0730-725X(99)00110-1